Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Strides Pharma Science Ltd (SRID)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
880.00 -16.80    -1.87%
03/05 - Closed. Currency in INR ( Disclaimer )
  • Volume: 192,861
  • Bid/Ask: 876.00 / 877.50
  • Day's Range: 870.00 - 896.80
Type:  Equity
Market:  India
ISIN:  INE939A01011 
S/N:  STAR
Strides Pharma 880.00 -16.80 -1.87%

SRID Interactive Chart

 
Our live advanced Strides Pharma Science Ltd share price chart is interactive, allowing you to interact with the 2024 SRID data that is relevant to you.

You have the option to change the appearance of the interactive Strides Pharma Science Ltd stock charts by varying the time scale, chart type, zooming in to different sections and adding new studies or indicators such as RSI, MACD, EMA, Bollinger Bands, Fibonacci retracements and many more.

You can save your Strides Pharma stock studies and create your own systems as well as having the option to set the colours of each object on the chart by logging into your free investing account.
Sign In / Free Sign Up now to save your chart settings.
press ESC to exit fullscreen mode
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SRID Price Commentary

Write your thoughts about Strides Pharma Science Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Lalit Choudhary
Lalit Choudhary Mar 01, 2022 14:20
Saved. See Saved Items.
This comment has already been saved in your Saved Items
target long term
No Options
No Options Mar 01, 2022 14:20
Saved. See Saved Items.
This comment has already been saved in your Saved Items
200
hemant thakkar
hemant thakkar Oct 15, 2021 15:11
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sale on Every Rise, Exit this counter fair value 420 to 440
DANIEL ANTHONY
DANIEL ANTHONY Oct 10, 2021 17:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
immediate Target 700+
Pravin Jain
Pravin Jain Sep 23, 2021 12:34
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Tomorrow definitely 650
Vishnu Velayudhan
Vishnu Velayudhan Sep 23, 2021 12:34
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yes
Suresh Suresh
Suresh Suresh Sep 22, 2021 7:09
Saved. See Saved Items.
This comment has already been saved in your Saved Items
End of the day Again 580?
Lalit Choudhary
Lalit Choudhary Jul 22, 2021 12:05
Saved. See Saved Items.
This comment has already been saved in your Saved Items
target of this share??
Lalit Choudhary
Lalit Choudhary May 25, 2021 15:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what is the target of this share
kunchok lhadon
kunchok lhadon Apr 21, 2020 7:25
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sooner or later pharma companies will be market leader
mohammed ibrahim
mohammed ibrahim Feb 12, 2020 20:16
Saved. See Saved Items.
This comment has already been saved in your Saved Items
target 780 month of April
Vikas Malde
Vikas Malde Jul 15, 2019 8:17
Saved. See Saved Items.
This comment has already been saved in your Saved Items
stop plus 361
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email